Evaluating the effects of standardized hydroalcoholic extract of marmotti (Salvia mirzayanii Rech. f. & Esfand) capsule as adjunctive treatment in patient with helicobacter pylori infectio
Phase 2
Recruiting
- Conditions
- Helicobacter pylori.Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhereB96.81
- Registration Number
- IRCT20110310006026N9
- Lead Sponsor
- Kerman University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 66
Inclusion Criteria
Patient with dyspepsia and gastrointestinal symptoms with Helicobacter pylori infection who diagnosed with stool antigen test
Exclusion Criteria
Earlier treatment of Helicobacter pylori eradication
Allergic to penicillin or marmotti
Stomach cancer
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Stool antigen. Timepoint: The first and second weeks after the beginning of the study and 4 weeks after the end of the study. Method of measurement: Stool antigen test.
- Secondary Outcome Measures
Name Time Method